ACON (Aclarion) Moat Score: 1/10 (As of Jun. 28, 2026)


ACON Aclarion Inc ACON
26 GF Score
Price $2.81
! 2 Warning Signs
View Full Analysis

What is Aclarion Moat Score?

Aclarion ACON +6.18% 26 Moat Score is 1 as of Jun. 28, 2026. GuruFocus rates ACON with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Aclarion ranks better than 74.89% on this metric.

Aclarion has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Aclarion has No Moat: Aclarion Inc has no discernible moat, with minimal market leadership, no significant intellectual property, and no durable cost advantages. The company operates in a competitive market with low barriers to entry.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Aclarion might have No Moat - Very weak/transient advantages.

Aclarion  (NAS:ACON) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Aclarion Moat Score Related Terms

ACON vs BRGX, MGRX, WLSS: Moat Score Comparison

For the Health Information Services subindustry, Aclarion's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aclarion Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aclarion's Moat Score distribution charts can be found below:

* The bar in red indicates where Aclarion's Moat Score falls into.


ACON
26GF Score
Aclarion Inc ACON
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Aclarion (ACON) has a Moat Score of 1 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Aclarion ranks #171 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 25.1%.
Is Aclarion's Moat Score too high?
Aclarion's current Moat Score is 1. Based on the distribution chart, Aclarion ranks #171 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Aclarion has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Aclarion's Moat Score compare to BRGX and MGRX?
According to the Healthcare Providers & Services industry distribution chart, Aclarion ranks #171 out of 681 companies for Moat Score. This puts Aclarion in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Aclarion's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aclarion stock overvalued right now?
Aclarion (ACON) has a current Moat Score of 1. The current Moat Score is 1. Aclarion's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Aclarion (ACON), the current Moat Score is 1 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aclarion Business Description

Other Exchanges IT20:Germany
Address 8181 Arista Place, Suite 100, Broomfield, CO, USA, 80021
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
26GF Score

Get the complete analysis for ACON

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.81
Price